Intended for healthcare professionals

CCBYNC Open access

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

BMJ 2011; 342 doi: (Published 14 June 2011) Cite this as: BMJ 2011;342:d3215

Chronic Obstructive Pulmonary Artery Disease

Dear Sir,

COPD is always a disease of the pulmonary artery system. (1)

Only low-dose Coumarin (INR 2,0) is a beneficial drug in
seriously ill patients.

Recurrent pulmonary artery thrombo-embolism should be prevented.

And there will be no studies, because Coumarin is too cheap.

And nobody will pay for such studies.

Best wishes

Yours, Friedrich Flachsbart

1. W. M. Thurlbeck, A. M. Churg: Pathology of the Lung
Sec. Edition.
Thieme Medical Publishers Inc., New York, 1995

Competing interests: No competing interests

23 June 2011
Friedrich Flachsbart
General Practitioner
Private Praxis